HM Payson & Co’s Globus Medical GMED Stock Holding History

HM Payson & Co’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-66	Closed	-$4K	–	1026
2022 Q2	$4K	Buy	+66	New	+$4.34K	﹤0.01%	910

Other funds holding GMED

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HM Payson & Co's GMED Position: Q3 2022 in Review

HM Payson & Co sold out of Globus Medical (GMED) in Q3 2022, closing a stake of 66 shares — an estimated $4K sold.

HM Payson & Co first reported a position in GMED in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

HM Payson & Co reported no remaining Globus Medical position as of Q3 2022 after selling out during the quarter.
HM Payson & Co sold 66 Globus Medical shares in Q3 2022, an estimated $4K.
HM Payson & Co first reported a position in Globus Medical in Q2 2022 and held it in 1 quarter.
HM Payson & Co's Globus Medical position peaked at $4K in Q2 2022.
370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.